221 related articles for article (PubMed ID: 4181574)
1. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
Cittadini E; Quartararo P; Romano F
Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
[No Abstract] [Full Text] [Related]
2. [Normal sequential treatment. experiences with an 11:10 variant of the sequential method for contraception and for medical indications].
Schmidt H; Langner A; Kaiser R
Munch Med Wochenschr; 1970 Oct; 112(42):1903-13. PubMed ID: 4097638
[No Abstract] [Full Text] [Related]
3. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
Ebeling K; Kühndel K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
[No Abstract] [Full Text] [Related]
4. Modified sequential oral contraception employing mestranol with chlormadinone.
Tyler ET; Matsner EM; Gotlib M
Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
[No Abstract] [Full Text] [Related]
5. [Oral contraception and gynecologic therapy].
Käsemann W
Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
[TBL] [Abstract][Full Text] [Related]
6. [Menstruation and endometrium after hormonal contraception].
Böhm W; Klinger G; Hempel E
Zentralbl Gynakol; 1972 Jul; 94(30):945-51. PubMed ID: 4118151
[No Abstract] [Full Text] [Related]
7. [Indications for the treatment with sequence preparations].
Breckwoldt M; Bettendorf G
Zentralbl Gynakol; 1969 Aug; 91(35):1147-50. PubMed ID: 4189508
[No Abstract] [Full Text] [Related]
8. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
Tyler ET
Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
[No Abstract] [Full Text] [Related]
9. [Experience in the use of chlormadinone acetate-mestranol mixed tablet (S-3850 tablet)].
Toyama J; Murata H; Itakura E; Sumi K; Sugawara T
Sanfujinka No Jissai; 1967 Apr; 16(4):364-72. PubMed ID: 4168671
[No Abstract] [Full Text] [Related]
10. [Experiences with Ovosiston in a new dosage form].
Zwahr C
Dtsch Gesundheitsw; 1970 Apr; 25(14):635-9. PubMed ID: 4098545
[No Abstract] [Full Text] [Related]
11. Fertility control with 15-8-5.
Andelman MB
Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
[No Abstract] [Full Text] [Related]
12. [Clinical and morphological studies on hormonal contraception with the sequential method].
Fettig O; Kopecky P
Geburtshilfe Frauenheilkd; 1968 Jun; 28(6):540-53. PubMed ID: 4098858
[No Abstract] [Full Text] [Related]
13. [Sequential therapy in menstruation disorders].
Gaudefroy M; Lefebvre F
J Sci Med Lille; 1968 Oct; 86(10):581-606. PubMed ID: 4097276
[No Abstract] [Full Text] [Related]
14. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate].
Zorrilla E
Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432
[No Abstract] [Full Text] [Related]
15. [Clinical application of the mixture of mestranol and chlormadinone for functional anomaly of the ovary].
Kobayshi T; Amenomori Y; Nagai N; Egusa M; Ichikawa T
Saishin Igaku; 1966 Sep; 21(9):2089-94. PubMed ID: 4166819
[No Abstract] [Full Text] [Related]
16. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
[No Abstract] [Full Text] [Related]
17. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
Zwahr C
Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
[No Abstract] [Full Text] [Related]
18. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive.
Christie GA
Med J Aust; 1969 Jul; 2(4):185-9. PubMed ID: 4184973
[No Abstract] [Full Text] [Related]
19. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
Krause W; Böhm W; Müller W
Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
[No Abstract] [Full Text] [Related]
20. [Two-stage therapy as a method of hormonal contraception in comparison with compound preparations].
Rothe K
Z Gesamte Hyg; 1970 Apr; 16(4):289-90. PubMed ID: 4108397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
